170.88 USD
↘ 0.67 (0.39%)AT CLOSE (11:59 AM EDT)
Neurocrine Biosciences Inc
NBIXNASDAQ • USD
171.60
↗ 0.72 (0.42%)
POST MARKET (AS OF 07:58 PM EDT)
Post Market
AS OF 07:58 PM EDT
171.60
↗ 0.72 (0.42%)
Market: CLOSED
NBIX is currently priced at $170.88. Our models show a "Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a robust Altman Z-Score, a bullish Golden Cross on the moving averages and bullish moving average alignment. On valuation, NBIX trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jul 17, 2026.
Open?$169.77
High?$172.57
Low?$169.26
Prev. Close?$171.55
Volume?929.8K
Avg. Volume?1.2M
VWAP?$170.70
Rel. Volume?0.78x
Bid / Ask
Bid?$160.73 × 100
Ask?$181.07 × 100
Spread?$20.34
Midpoint?$170.90
Valuation & Ratios
Market Cap?17.2B
Shares Out?100.5M
Float?96.4M
Float %?95.8%
P/E Ratio?25.80
P/B Ratio?5.06
EPS?$6.65
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.
Employees
2.0K
Market Cap
17.2B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1996-05-23
Address
6027 EDGEWOOD BEND COURT
SAN DIEGO, CA 92130
Phone: (858) 617-7600
SAN DIEGO, CA 92130
Phone: (858) 617-7600
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Golden Alignment
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?100
Momentum?79
Short Sent.?49
Piotroski F-Score?4/9Mixed
Altman Z-Score?8.61Safe
Confidence?66%Moderate
Short InterestElevated
Short % of Float?5.74%Elevated
Short Interest?5.5M
Days to Cover?4.2
Free Float96.4M
Avg Daily Volume1.3M
Settlement Date2026-06-30
Financial Health
Current Ratio?2.93Strong
Quick Ratio?2.85Strong
Cash Ratio?0.32Low
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score61/100
P/E?25.8FAIR▾
Peers100
S&P45
P/B?5.06FAIR▾
Peers100
S&P36
P/S?5.56FAIR▾
Peers100
S&P25
P/FCF?20.8FAIR▾
Peers100
S&P53
EV/EBITDA?20.5HIGH▾
Peers100
S&P24
EV/Sales?5.47FAIR▾
Peers100
S&P32
Returns & Efficiency
ROE?19.6%STRONG▾
Peers50
S&P65
ROA?13.6%STRONG▾
Peers50
S&P84
Cash Flow & Enterprise
FCF?$831.3M
Enterprise Value?$17.0B
Fundamentals ratios updated end of day